Table 3.
Group |
Body weight per rat (g) |
Liver weight per rat (g) |
|
---|---|---|---|
Prior to treatment | Post treatment | ||
NLP-C |
233.30 ± 20.8 |
278.60 ± 16.72 |
5.44 ± 0.22 |
HLP-C |
22.00 ± 14.71 |
334.50 ± 14.50 (+20.06%)α |
6.51 ± 0.01 (+19.65%)α |
HLP- ME |
221.25 ± 13.14 |
240.25 ± 9.74 (-28.18%)b |
5.48 ± 0.03 (-15.82%)b |
HLP-VO | 220.00 ± 10.80 | 250.75 ± 4.85 (-25.04%)b | 5.43 ± 0.07 (-16.59%)b |
Each value is mean ± SD from 4 rats in each group except NLP (n = 5). NLP-C, normolipidemic control fed 1 ml saline/rat/day; HLP-C, hyperlipidemic control given 1 ml of saline before the feeding of 1 ml suspension containing 5 mg cholesterol, 30 mg coconut oil and 2.5 mg cholic acid /rat/day; whereas rats in HLP-ME, HLP-VO were fed 1 ml of 100 mg ME, 20 mg VO prior to administration of 1 ml of the above atherogenic suspension /rat/day for 30 days. Note: All the values in NLP-C and HLP-C control groups in this manuscript were already presented in our previously published article [37]. The values were statistically significant from NLP-C at ap < 0.05 and HLP-C at bp < 0.05.